Addyi was initially accepted by the FDA in August 2015 to treat hypoactive sexual motivation problem (HSDD) in premenopausal women. Which is just another way of claiming it boosts sex travel (also called libido) in Girls that have not arrived at menopause. It had been the first these drug authorized https://bostanli.yesilyurtcilingir.net/